US EditionPublished • loading... • Updated
Analysts Set Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Target Price at $43.20
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Analysts Set Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Target Price at $43.20
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) has earned an average rating of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year price […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
